very interesting...but stupid

interesting this announcement has the amount of $400k paid upfront for Zolpmist for 3 jurisdictions plus options for a further 3 jurisdictions with the possible further payments up to $2.3m ....... plus royalties.
We also had an upfront payment of $400k (plus further incentive payments) plus royalty payments for the jurisdiction of China.
If I remember correctly Suda Ltd purchased ALL of its current product range (except for Artimist) for ALL of the world for $400k plus a small quantity of shares.
One product sold in 4 four jurisdictions has given the company a very good return for its initial investment of $400k plus stock......and more products and places to sell too.
Will also be interesting to see what comes from Pfizer feasibility agreement.

stupid has been the market response for the last few years on all positive Suda announcements.Looks like a mix of old hands wanting out and someone playing games.